María Angeles Zulet Alzórriz-rekin lankidetzan egindako argitalpenak (236)

2024

  1. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

    Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418

  2. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

  3. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

    Psychological Medicine, Vol. 54, Núm. 3, pp. 620-630

  4. Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

    Environment International, Vol. 186

  5. Impact of mediterranean diet promotion on environmental sustainability: a longitudinal analysis

    Public Health, Vol. 230, pp. 12-20

  6. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

    Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781

  7. Microbial Phenolic Metabolites Are Associated with Improved Cognitive Health

    Molecular Nutrition and Food Research, Vol. 68, Núm. 2

  8. Precision nutrition impact on metabolic health and quality of life in aging population after a 3-month intervention: A randomized intervention

    Journal of Nutrition, Health and Aging, Vol. 28, Núm. 7

  9. Sex-specific dietary patterns and their association with metabolic syndrome: Insights from a cross-sectional analysis

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 18, Núm. 9

2023

  1. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

    BMC Medicine, Vol. 21, Núm. 1

  2. Carbon dioxide (CO2) emissions and adherence to Mediterranean diet in an adult population: the Mediterranean diet index as a pollution level index

    Environmental Health: A Global Access Science Source, Vol. 22, Núm. 1

  3. Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)

    Frontiers in Endocrinology

  4. Dietary diversity and depression: Cross-sectional and longitudinal analyses in Spanish adult population with metabolic syndrome. Findings from PREDIMED-Plus trial

    Public Health Nutrition, Vol. 26, Núm. 3, pp. 598-610

  5. Dietary intake of polychlorinated dibenzo-p-dioxins and furans, adiposity and obesity status.

    Environmental Research, Vol. 227

  6. Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

    American Journal of Clinical Nutrition, Vol. 118, Núm. 2, pp. 360-368

  7. Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat

    Clinical Nutrition, Vol. 42, Núm. 4, pp. 477-485

  8. Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial

    Atherosclerosis, Vol. 377, pp. 12-23

  9. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial

    Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167

  10. Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

    Globalization and health, Vol. 19, Núm. 1, pp. 50

  11. Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome

    Journal of Alzheimer's Disease, Vol. 95, Núm. 3, pp. 887-899